Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,571 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma.
Sato Y, Nabeta Y, Tsukahara T, Hirohashi Y, Syunsui R, Maeda A, Sahara H, Ikeda H, Torigoe T, Ichimiya S, Wada T, Yamashita T, Hiraga H, Kawai A, Ishii T, Araki N, Myoui A, Matsumoto S, Umeda T, Ishii S, Kawaguchi S, Sato N. Sato Y, et al. Among authors: wada t. J Immunol. 2002 Aug 1;169(3):1611-8. doi: 10.4049/jimmunol.169.3.1611. J Immunol. 2002. PMID: 12133991
Improved generation of HLA class I/peptide tetramers.
Sato Y, Sahara H, Tsukahara T, Kondo M, Hirohashi Y, Nabeta Y, Kawaguchi S, Ikeda H, Torigoe T, Ichimiya S, Tamura Y, Wada T, Yamashita T, Goto M, Takasu H, Sato N. Sato Y, et al. Among authors: wada t. J Immunol Methods. 2002 Dec 20;271(1-2):177-84. doi: 10.1016/s0022-1759(02)00329-0. J Immunol Methods. 2002. PMID: 12445740
Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substitute.
Ida K, Kawaguchi S, Sato Y, Tsukahara T, Nabeta Y, Sahara H, Ikeda H, Torigoe T, Ichimiya S, Kamiguchi K, Wada T, Nagoya S, Hiraga H, Kawai A, Ishii T, Araki N, Myoui A, Matsumoto S, Ozaki T, Yoshikawa H, Yamashita T, Sato N. Ida K, et al. Among authors: wada t. J Immunol. 2004 Jul 15;173(2):1436-43. doi: 10.4049/jimmunol.173.2.1436. J Immunol. 2004. PMID: 15240740
SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group.
Kawaguchi S, Tsukahara T, Ida K, Kimura S, Murase M, Kano M, Emori M, Nagoya S, Kaya M, Torigoe T, Ueda E, Takahashi A, Ishii T, Tatezaki S, Toguchida J, Tsuchiya H, Osanai T, Sugita T, Sugiura H, Ieguchi M, Ihara K, Hamada K, Kakizaki H, Morii T, Yasuda T, Tanizawa T, Ogose A, Yabe H, Yamashita T, Sato N, Wada T. Kawaguchi S, et al. Among authors: wada t. Cancer Sci. 2012 Sep;103(9):1625-30. doi: 10.1111/j.1349-7006.2012.02370.x. Epub 2012 Aug 7. Cancer Sci. 2012. PMID: 22726592 Free PMC article. Clinical Trial.
Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor.
Tsukahara T, Nabeta Y, Kawaguchi S, Ikeda H, Sato Y, Shimozawa K, Ida K, Asanuma H, Hirohashi Y, Torigoe T, Hiraga H, Nagoya S, Wada T, Yamashita T, Sato N. Tsukahara T, et al. Among authors: wada t. Cancer Res. 2004 Aug 1;64(15):5442-8. doi: 10.1158/0008-5472.CAN-04-0522. Cancer Res. 2004. PMID: 15289353
A quest for therapeutic antigens in bone and soft tissue sarcoma.
Kawaguchi S, Wada T, Tsukahara T, Ida K, Torigoe T, Sato N, Yamashita T. Kawaguchi S, et al. Among authors: wada t. J Transl Med. 2005 Aug 8;3:31. doi: 10.1186/1479-5876-3-31. J Transl Med. 2005. PMID: 16086842 Free PMC article.
4,571 results